Back to search

Article

The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs

2022-11-11

Abstract excerpt

Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinical approval in the United States and Europe for its ability to prevent EBOV disease. Analogous rVSV vaccines expressing the glycoproteins of different human-pathogenic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40b81b2f-8b01-5cc1-97b9-f7a63acaeafa
DOI
10.1101/2022.11.11.516195
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigsDOI 10.1101/2022.11.11.516195
Select a neighboring publication to make it the new centre.